Use of mycophenolate mofetil in patients with pediatric and adult primary nephrotic syndrome: information from a japanese hospital claims database

HIGHLIGHTS

• who: Takashi Funatogawa from the information is available on patients with primary nephrotic syndrome who receive off-label treatment with MMF in Japan have published the research work: Use of mycophenolate mofetil in patients with pediatric and adult primary nephrotic syndrome: information from a Japanese hospital claims database, in the Journal: (JOURNAL) of 14/04/2021
• what: This is the first study to investigate the actual usage of MMF for primary nephrotic syndrome in Japan using a large database which held prescription records on about 36 million patients, however, this study had several limitations.
 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.